Cargando…
Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against Mycobacterium tuberculosis
Novel drug regimens against tuberculosis (TB) are urgently needed and may be developed by targeting essential enzymes of Mtb that sustain the pathogenicity of tuberculosis. In the present investigation, series of compounds (5a–f and 6a–f) based on a naturally occurring rugosaflavonoid moiety were ev...
Autores principales: | Puranik, Ninad V., Srivastava, Pratibha, Swami, Sagar, Choudhari, Amit, Sarkar, Dhiman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078922/ https://www.ncbi.nlm.nih.gov/pubmed/35540494 http://dx.doi.org/10.1039/c8ra00636a |
Ejemplares similares
-
Evaluation of the
Antiviral Potential of Halogenated Dihydrorugosaflavonoids and Molecular
Modeling with nsP3 Protein of Chikungunya Virus (CHIKV)
por: Puranik, Ninad V., et al.
Publicado: (2019) -
Acetylene containing 2-(2-hydrazinyl)thiazole derivatives: design, synthesis, and in vitro and in silico evaluation of antimycobacterial activity against Mycobacterium tuberculosis
por: Maganti, Lakshmi Haritha Bharathi, et al.
Publicado: (2022) -
In Vitro Evaluation of Novel Nitazoxanide Derivatives
against Mycobacterium tuberculosis
por: Odingo, Joshua, et al.
Publicado: (2017) -
Novel Trifluoromethyl Pyrimidinone Compounds With Activity Against Mycobacterium tuberculosis
por: Hembre, Erik, et al.
Publicado: (2021) -
Synthesis, biological evaluation and computational studies of pyrazole derivatives as Mycobacterium tuberculosis CYP121A1 inhibitors
por: Alshabani, Lama A., et al.
Publicado: (2022)